Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Array BioPharma Inc.
Array BioPharma Announces Eighteen Abstracts Selected for Presentation at 2009 AACR Annual Meeting
April 25th, 2009
Array BioPharma Inc. (NASDAQ: ARRY) announced that eighteen abstracts have been selected for presentation at the American Association for Cancer Research (AACR) Annual Meeting, being held from April 18-22, 2009, in Denver, Colorado. Presentations will disclose new findings about seven of its anti-cancer programs: ARRY-520, ARRY-543, ARRY-614, ARRY-380, AZD6244 (ARRY-886), AZD8330 (ARRY-704), and an emerging program for Chk1 inhibition. The abstracts can be accessed through the AACR website, www.aacr.org. Abstract titles are provided below, however, please note that according to AACR policy, all data is embargoed until the time of the beginning of the presentation. All...
Source: Law & Health Weekly (2009-04-25)
|
